• AXIM® Biotechnologies Completes Pre-Clinical Drug Studies on New Compound Proving Tenfold Greater Inhibition of Tumor Metastasis Than Parent Compound

    12 days ago - By San Diego Biotechnology

    SAN DIEGO, March 24, 2020 - AXIM® Biotechnologies, Inc. (“AXIM® Biotech,” “AXIM” or “the Company”), an international healthcare solutions com...
    Read more ...